Newstral
Article
Fft.com on 2016-02-07 18:34
AstraZeneca cancer drug breakthrough
Related news
- FAstraZeneca to supply cancer drug to NHSft.com
- FDrug breakthrough for prostate cancerft.com
- BAstraZeneca Jumps on Strong Cancer Drug Databarrons.com
- FFDA deals blow to AstraZeneca cancer drugft.com
- FAstraZeneca suffers lung cancer drug trial setbackft.com
- AstraZeneca PLC: AstraZeneca hails ‘clinically meaningful’ cancer drug trial resultsFinancial Times
- FAstraZeneca PLC: Cancer drug sales help AstraZeneca beat forecastsft.com
- FAstraZeneca heart drug suffers failureft.com
- FAstraZeneca pins hopes on novel breast cancer drugft.com
- AstraZeneca withdraws application for ovarian cancer drug in Europebizjournals.com
- FAstraZeneca receives US boost for key cancer drugft.com
- BAstraZeneca Climbs as New Cancer Drug Sales Soarbarrons.com
- BAstraZeneca Can't Boost a Cancer Drug Stockpile for Brexitbloomberg.com
- FAstraZeneca shares fall after trial setback for cancer drugft.com
- FDA approves AstraZeneca drug for advanced lung cancerwkrg.com
- Cancer treatments offset tumbling Covid drug sales at AstraZenecaShropshire Star
- AShares in AstraZeneca dive as key cancer drug trial failsapnewsarchive.com
- TAstraZeneca breast cancer drug Lynparza is approved by EU regulatorsthisismoney.co.uk
- ECMC cancer center selected for AstraZeneca drug trialbizjournals.com
- AstraZeneca to trial blood cancer drug as Covid-19 treatmentNew Statesman